C-1311. Antineoplastic

Drugs of the Future

Volumn 23, Issue 7, 1998, Pages 702-706

  Mazerska, Zofia ^a   Augustin, Ewa ^a   Skladanowski, Andrzej ^a   Bibby, Michael C ^b   Double, John A ^b   Konopa, Jerzy ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; FLUOROURACIL; IMIDACRINE; IMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CANCER GRAFT; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE;

EID: 0031692144     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1998.023.07.463751     Document Type: Article

References (27)

1. Cholody, W.M., Martelli, S., Konopa, J. Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias. J Med Chem 1992, 35: 378-82.
2. Capps, D.B. (Warner-Lambert Co.). Pyrazolo[3,4,5-k]acridine cpds., pharmaceutical compsns. containing the same and processes for their production. EP 138302.
3. Cheng, C.C., Zee-Cheng, R.K.Y. The design, synthesis and development of a new class of potent antineoplastic anthraquinones. In: Progress in Medicinal Chemistry, G.P. Ellis and G.B. West (Eds.), Elsevier Science Publishers, B.V., New York, 1989, 83-118.
4. Konopa, J., Skladanowski, A. Mitoxantrone induces covalent interstrand DNA crosslinking in tumor cells. In: Recent Advances in Chemotherapy, J. Ishigami (Ed.), University of Tokyo Press, Tokyo, 1985, 633-4.
5. Konopa, J. Interstrand DNA crosslinking in tumor cells by 1-nitroacridines, anthracyclines and aminoanthraquinones. Pharmacol Ther 1990, 7(Suppl.): 83-94.
6. Cholody, W.M., Martelli, S., Lukowicz, J., Konopa, J. 5-[(Aminoalky/)amino]-imidazo[4,5,1-de]acridin-6-ones as a novel class of antineoplastic agents. Synthesis and biological activity. J Med Chem 1990, 33: 49-52.
7. Cholody, W.M., Martelli, S., Konopa, J. 8-Substituted 5-[(aminoalkyl)amino]-6H-v-triazolo[4,5,1 -de]acridin-6-ones as potential antineoplastic agents. Synthesis and biological activity. J Med Chem 1990, 33: 2852-6.
8. Konopa, J., Wysocka-Skrzela, B., Horowska, B. 4-Substituted 1-alkylenediaminoacridones as potential antitumor agents. 7th NCI-EORTC Symp New Drugs Cancer Ther (March 17-20, Amsterdam) 1992, Abst 119.
9. Cholody, W.M., Horowska, B., Paradziej-Lukowicz, J., Martelli, S., Konopa, J. Structure-activity relationship for antineoplastic imidazoacridinones: Synthesis and antileukemic activity in vivo. J Med Chem 1996, 39: 1028-32.
10. Burger, A.M., Double, J.A., Konopa, J., Bibby, M.C. Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer. Brit J Cancer 1996, 74: 1369-74.
11. Berger, B., Marquardt, H., Westendorf, J. Pharmacological and toxicological aspects of new imidazoacridinone antitumor agents. Cancer Res 1996, 56. 2094-104.
12. Augustin, E., Wheatley, D.N., Lamb, J., Konopa, J. Imidazoacridinones arrest cell-cycle progression in the G2 phase of L1210 cells. Cancer Chemother Pharmacol 1996, 38: 39-44.
13. Jackson, R.C., Sebolt, J.S., Shillis, J.L., Leopold, W.R. The pyrazoloacridines: Approaches to the development of a carcinoma-selective cytotoxic agent. Cancer Invest 1990, 8: 39-47.
14. Skladanowski, A., Plisov, S.Y., Konopa, J., Larsen, K.L. Inhibition of DNA topoisomerase II by imidazoacridinones, new antineoplastic agents with strong activity against solid tumors. Mol Pharmacol 1996, 49: 772-80.
15. Warr, J.R., Quinn, D.M., Double, J.A., Bibby, M.C. Low level multidrug resistance expression to C-1311, a potential clinical candidate. Brit J Cancer 1997, 75: 33.
16. Skladanowski, A., Come, M.G., Laurent, G., Konopa, J., Larsen, A.K. PSC-833 and tubulin interacting agents reverse the altered drug distribution in multidrug resistant HL-60 cells as revealed by the fluorescent antitumor drug imidacrine. Proc Amer Assoc Cancer Res 1997, 38: Abst 3990.
17. Dziegielewski, J., Skladanowski, A., Konopa, J. Noncovalent binding of potent antitumor imidazoacridinones to DNA. Ann Oncol 1996, 7(Suppl. 1): 56.
18. Dziegielewski, J., Konopa, J. Interstrand crosslinking of DNA induced in tumor cells by a new group of antitumor imidazoacridinones. Proc Amer Assoc Cancer Res 1996, 37: Abst 2800.
19. Mazerska, Z., Gorlewska, K., Kraciuk, A., Konopa, J. The relevance of enzymatic oxidation by horseradish peroxidase to antitumor potency of imidazoacridinone derivatives. Chem Biol Interact 1998, in press.
20. Mazerska, Z., Zamponi, S., Marassi, R., Martelli, S., Konopa, J. Electrochemical oxidation of antitumor imidazoacridinone derivatives and the reference 2-hydroxyacridinone. J Electroanal Chem 1997, 427: 71-8.
21. Wheatley, D.N., Lamb, J. Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentration coincident with dose-differentiated cell cycle perturbation. Brit J Cancer 1996, 74: 1359-61.
22. 2 phase of the HT29 cells. J Comp Assist Microsc 1997, 9: 21.
23. Augustin, E., Konopa, J. Imidazoacridinones induce apoptosis in murine leukemia L1210 cells. Fol Cytochem Cytobiol 1996, 34(Suppl. 2): 56.
24. Calabrese, C.R., Loadman, P.M. Analysis of the imidazoacridinone C1311 by high-performance liquid chromatography. J Chromatogr B 1997, 690: 275-81.
25. Calabrese, C.R., Bibby, M.C., Double, J.A., Loadman, P.M. Pharmacokinetics and tissue distribution of the imidazoacridinone C-1311 in tumor bearing mice. Cancer Chemother Pharmacol 1998, in press.
26. Calabrese, C.R., Loadman, P.M., Bibby, M.C., Double, J.A. Anti-tumor activity and pharmacokinetics following oral administration of C-1311. Proc Amer Assoc Cancer Res 1997, 38: Abst 2057.
27. Calabrese, C.R., Loadman, P.M., Bibby, M.C., Double, J.A. Assessment of murine metabolism of the imidazoacridinone C-1311. Brit J Cancer 1997, 75(Suppl. 1): 22.